Solly Malatsi, communications and digital technologies minister. For the first time since becoming the Department of Communications and Digital Technologies (DCDT) in 2020, the department has a full ...
A unit about the size of an air conditioner, mounted in the side yard, could soon be humming away on artificial intelligence tasks, drawing power from your home’s energy supply and earning you ...
SINGAPORE - An expanded definition of family – one that includes grandparents, aunts and uncles – and encouraging families to help those beyond their kin are among the shifts that Mr Keith Magnus ...
The number of C4A gene copies is associated with the risk of schizophrenia in genome-wide association studies of individuals with European ancestry. Higher C4A gene expression is associated with ...
The term “affordable mass” entered public defense discourse in 2021 as a munitions concept, which the Air Force adopted in 2023 to describe its effort to field large numbers of lower-cost, ...
GLP-1 medications don’t target where the fat comes off, which is why some say CoolSculpting complements the process, targeting stubborn areas. Justice Jackson pens unanimous decision backed by SCOTUS ...
Abstract: A method for performing continuous error detection and correction of arithmetic is disclosed which utilizes a redundant residue number system (RRNS) and ...
Abstract: This paper presents techniques for low-power addition/subtraction in the logarithmic number system (LNS) and quantifies their impact on digital filter VLSI implementation. The impact of ...
The nature of the threat in complex, tech-driven war zones is increasingly unpredictable. Simple rockets, artillery shells, swarming drones, low-cost projectiles, and complex missile volleys now ...
Energy Secretary Ed Miliband's promise to cut energy bills by £300 could be "wiped out" by rising electricity costs, according to the expert behind the savings estimate. Miliband's pledge - which he ...
Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...
The F-47 is expected to replace or complement existing fifth-generation fighters, such as the F-22 Raptor, with initial operational capability anticipated sometime in the late 2020s or early 2030s.